263 related articles for article (PubMed ID: 8275488)
1. Loss of heterozygosity and p53 gene mutations in breast cancer.
Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
[TBL] [Abstract][Full Text] [Related]
2. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
[TBL] [Abstract][Full Text] [Related]
3. The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer.
Bhargava V; Thor A; Deng G; Ljung BM; Moore DH; Waldman F; Benz C; Goodson W; Mayall B; Chew K
Mod Pathol; 1994 Apr; 7(3):361-8. PubMed ID: 8058709
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
5. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
Okamoto A; Sameshima Y; Yamada Y; Teshima S; Terashima Y; Terada M; Yokota J
Cancer Res; 1991 Oct; 51(20):5632-5. PubMed ID: 1913680
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the p53 gene in primary human breast cancers.
Osborne RJ; Merlo GR; Mitsudomi T; Venesio T; Liscia DS; Cappa AP; Chiba I; Takahashi T; Nau MM; Callahan R
Cancer Res; 1991 Nov; 51(22):6194-8. PubMed ID: 1682043
[TBL] [Abstract][Full Text] [Related]
7. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
[TBL] [Abstract][Full Text] [Related]
8. p53 mutations and histological type of invasive breast carcinoma.
Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M
Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
10. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP.
Chen YH; Li CD; Yap EP; McGee JO
J Pathol; 1995 Oct; 177(2):129-34. PubMed ID: 7490678
[TBL] [Abstract][Full Text] [Related]
11. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
[TBL] [Abstract][Full Text] [Related]
12. The role of p53 mutations in bilateral breast carcinoma.
Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ
Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
14. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
[TBL] [Abstract][Full Text] [Related]
15. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
16. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
[TBL] [Abstract][Full Text] [Related]
17. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
Frankel RH; Bayona W; Koslow M; Newcomb EW
Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
[TBL] [Abstract][Full Text] [Related]
19. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.
McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG
J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210
[TBL] [Abstract][Full Text] [Related]
20. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis.
Koreth J; Bethwaite PB; McGee JO
J Pathol; 1995 May; 176(1):11-8. PubMed ID: 7616353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]